Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
filingDate |
2018-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-109395085-B |
titleOfInvention |
Pharmaceutical composition for treating neuroblastoma and glioma and application thereof |
abstract |
The invention relates to a pharmaceutical composition for treating neuroblastoma and glioma, which comprises a composition consisting of statin and abiraterone acetate or salt thereof, preferably simvastatin or fluvastatin and abiraterone acetate. The pharmaceutical composition of the invention can achieve significant synergistic effect in the treatment of neuroblastoma and glioma. |
priorityDate |
2018-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |